Drug Database
CI

ciclometasone (Cycloderm / ciclometasone / Telocort Spray)

✓ Approved

Sanofi S.A · NR3C1 · Small Molecule

What is ciclometasone?

ciclometasone is a small molecule developed by Sanofi S.A. It is approved for therapeutic indications.

Drug Profile

Brand NamesCycloderm, ciclometasone, Telocort Spray
CompanySanofi S.A
Drug ClassSmall Molecule
Molecular TargetNR3C1
StatusApproved
Sources: ClinicalTrials.gov, Sanofi S.A

Mechanism of Action

Molecular Targets

ciclometasone acts on 1 molecular target:

NR3C1nuclear receptor subfamily 3 group C member 1 (GR, GCCR)
Want deeper analysis?Noah AI can explain complex mechanisms and compare to similar drugs.

Therapeutic Indications

ciclometasone is developed for 1 unique indication across 1 therapeutic area.

Therapeutic AreaConditionPhase
Skin and subcutaneous tissue disordersDermatitis atopic✓ Approved

Ask about ciclometasone